Exploratory Analysis of Ancestry‐Informed Polygenic Risk Scores in Korean Patients With Mature B‐Cell Neoplasms
Journal of Clinical Laboratory Analysis · 05.11.2026
DOI: 10.1002/jcla.70396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 05.11.2026. Verfasst von Youngeun Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Republic of Korea. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chungbuk National University.
Abstract (Originalsprache)
Background
Polygenic risk scores (PRS) capture cumulative germline susceptibility and have demonstrated clinical relevance in multiple complex diseases. However, data on PRS performance in mature B‐cell neoplasms remain limited, particularly in East Asian populations.
Methods
We analyzed 246 Korean patients with mature B‐cell neoplasms and related plasma‐cell disorders. GWAS‐derived susceptibility variants were filtered for genome‐wide significance and pruned for linkage disequilibrium using the 1000 Genomes East Asian (EAS) reference population, followed by cross‐dataset genotype harmonization. A 37‐SNP cross‐entity score was constructed together with phenotype‐matched PRS for multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and diffuse large B‐cell lymphoma (DLBCL).
Results
The overall 37‐SNP score was modestly but significantly higher in cases than in the 1000 Genomes EAS reference population ( p = 0.024; OR per 1‐SD, 1.19; 95% CI, 1.02–1.38). A more distinct association emerged for MM: the MM‐specific PRS was associated with higher odds of disease (OR per 1‐SD, 1.386; 95% CI, 1.149–1.672; p = 0.000642), whereas CLL and DLBCL were not significant. Although discrimination remained modest (AUC, 0.594 for MM), MM cases were enriched above the EAS 95th percentile (OR, 2.21; p = 0.026), and rs7193541 and rs6599175 remained significant after false‐discovery‐rate correction.
Conclusions
Ancestry‐informed PRS identified a detectable polygenic component in Korean patients with mature B‐cell malignancies and related plasma‐cell disorders, with the most consistent evidence observed for MM. These findings support further evaluation of disease‐specific, ancestry‐informed PRS approaches rather than broadly aggregated susceptibility models.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
- Department of Laboratory Medicine, Chungbuk National University College of Medicine, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
- Department of Internal Medicine, Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
- Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju-si, Chungcheongbuk-do, Republic of Korea.
ORCID-Profile: Yong-Pyo Lee, Hee Sue Park
Förderung
- Chungbuk National University
Zitieren
APA
Lee, Y., Son, B. R., Lee, Y. P., Kwon, J., & Park, H. S. (2026). Exploratory Analysis of Ancestry‐Informed Polygenic Risk Scores in Korean Patients With Mature B‐Cell Neoplasms. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70396
Vancouver
Lee Y, Son BR, Lee YP, Kwon J, Park HS. Exploratory Analysis of Ancestry‐Informed Polygenic Risk Scores in Korean Patients With Mature B‐Cell Neoplasms. Journal of Clinical Laboratory Analysis. 2026. doi:10.1002/jcla.70396
BibTeX
@article{Lee2026,
author = {Lee, Youngeun and Son, Bo Ra and Lee, Yong-Pyo and Kwon, Jihyun and Park, Hee Sue},
title = {Exploratory Analysis of Ancestry‐Informed Polygenic Risk Scores in Korean Patients With Mature B‐Cell Neoplasms},
journal = {Journal of Clinical Laboratory Analysis},
year = {2026},
doi = {10.1002/jcla.70396}
}
EUVIMED